MMP-13 binds to platelet receptors αIIbβ3 and GPVI and impairs aggregation and thrombus formation

Joanna-Marie Howes1, Nicholas Pugh2, Samir W Hamaia1

  • 1Department of Biochemistry University of Cambridge Cambridge UK.

Insights

Matrix metalloproteinase-13 (MMP-13) inhibits platelet aggregation and thrombus formation by binding to platelet receptors. This discovery offers new insights into atherothrombotic pathologies.

Area of Science:

  • Cardiovascular Biology
  • Thrombosis Research
  • Molecular Medicine

Background:

  • Atherosclerotic plaque rupture triggers thrombus formation, leading to myocardial infarction and stroke.
  • Collagen exposure during plaque rupture activates platelets, initiating aggregation.
  • Other plaque components can influence platelet function and thrombus development.

Purpose of the Study:

  • To investigate the role of matrix metalloproteinase-13 (MMP-13) in platelet aggregation and thrombus formation.
  • To determine if MMP-13, upregulated in atherothrombotic conditions, impacts platelet function.

Main Methods:

  • Assessed MMP-13 binding to platelet receptors alphaIIbbeta3 (αIIbβ3) and glycoprotein (GP)VI.
  • Evaluated the effect of MMP-13 on washed platelet aggregation.
  • Measured thrombus formation on fibrillar collagen in flowing blood.

Main Results:

  • MMP-13 binds to platelet receptors αIIbβ3 and GPVI.
  • MMP-13 significantly inhibits washed platelet aggregation.
  • MMP-13 decreases thrombus formation on fibrillar collagen.

Conclusions:

  • MMP-13 inhibits platelet aggregation and thrombus formation in flowing blood.
  • MMP-13 may play a subtle role in atherothrombotic pathologies.
  • Findings suggest new research avenues for understanding MMP-13's mechanisms in cardiovascular disease.
Abstract

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.7K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K